Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513507 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.
A NA study of Rheumatoid Arthritis and Inflammatory Disease, sponsored by Raphael Pharma.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06513507 is a NA study of Rheumatoid Arthritis and Inflammatory Disease that is active but no longer recruiting, run by Raphael Pharma. The registered enrollment target is 12 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06513507, a NA study of Rheumatoid Arthritis and Inflammatory Disease, is active but no longer recruiting, sponsored by Raphael Pharma.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-group exploratory longitudinal prospective study lasting 8 weeks. The study aims to measure the efficacy of purified cannabigerol (CBG) in patients with active rheumatoid arthritis using laboratory and self-reported outcome measures.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Cannabigerol (CBG)
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06513507
The ClinicalTrials.gov registry entry for NCT06513507 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is Raphael Pharma, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Cannabigerol (CBG) is the first listed.
NCT06513507 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06513507 about?
NCT06513507 is a clinical study titled "A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.". This is a single-group exploratory longitudinal prospective study lasting 8 weeks. The study aims to measure the efficacy of purified cannabigerol (CBG) in patients with active rheumatoid arthritis using laboratory and self-reported outcome measures.
What is the current status of trial NCT06513507?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-06-03. Estimated completion is 2024-12-31.
What conditions does trial NCT06513507 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Inflammatory Disease.
What interventions are being tested in trial NCT06513507?
The interventions under investigation include: Cannabigerol (CBG) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06513507?
This trial is sponsored by Raphael Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513507 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.